Path Traversal in Generex Rccmd
CVE-2022-26041
Directory traversal vulnerability in RCCMD 4.26 and earlier allows a remote authenticated attacker with an administrative privilege to read or alter an arbitrary file on the server via unspecified vectors.
Vulnerability class: Path Traversal (Directory Traversal)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N.
EPSS exploit prediction
EPSS: 0.015 (73.6th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 74th percentile — 73.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.015 · newest: 0.015 · change: 0.000
Affected products
- Generex Rccmd
- Generex Systems Computervertriebsgesellschaft Mbh Rccmd — versions 4.26 and earlier
Weakness classification (CWE)
References
- www.generex.de/support/downloads/software/rccmd/update (Vendor Advisory)
- jvn.jp/en/jp/JVN60801132/index.html (Third Party Advisory)
Frequently asked questions
- What is CVE-2022-26041?
- CVE-2022-26041 is a medium-severity vulnerability in Generex Rccmd, classified under Path Traversal. CVSS score: 6.5/10. Published 2022-06-13.
- How severe is CVE-2022-26041?
- Medium severity. CVSS v3 base score is 6.5 out of 10.